SCHEMBL6479227

SCHEMBL6479227

Oc1cccc2[nH]c(-c3cc[nH]n3)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.38
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38
DAO P14920 4/20 0.36
DDO Q99489 3/20 0.36
IDO1 P14902 1/20 0.36
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
ITK Q08881 2/20 0.33
AR P10275 1/20 0.33
APP P05067 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6488916 0.81 DAO (0.46) HRH4DAOITK
SCHEMBL6478917 0.81 DAO (0.46) HRH4DAODDOITKAURKA
SCHEMBL6487991 0.81 ITK (0.50) HRH4ITKAURKAAURKB
SCHEMBL5802435 0.81 HRH4 (0.37) HRH4ALDH1A1ITKAURKAAURKB
SCHEMBL6488203 0.81 DAO (0.46) DAODDOKDM4EALDH1A1ITK
SCHEMBL5755265 0.80 PBRM1 (0.40) HRH4KDM4EALDH1A1GRIN2DGRIN3B
SCHEMBL5752743 0.79 PARP1 (0.40) KDM4EALDH1A1AURKB
SCHEMBL6480649 0.78 KIF11 (0.42) IDO1KDM4EALDH1A1ITKAR
SCHEMBL6480513 0.78 MAP2K1 (0.37) IMPDH2IMPDH1ITK
SCHEMBL6478752 0.76 NOS1 (0.44) HRH4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 HRH4 3130/4885IMPDH2 917/4885IMPDH1 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.